In a major development just before the US Open, the International Tennis Integrity Agency (ITIA) revealed that Jannik Sinner, the world’s top-ranked tennis player, tested positive for trace amounts of steroids in March. The substance, Clostebol, was detected during the ATP 1000 tournament in Indian Wells.
What Happened?
Jannik Sinner was found to have traces of Clostebol, a synthetic steroid, in his system. However, the ITIA determined that the Italian player did not intentionally take the substance. As a result, Sinner will not face severe consequences. The punishment is limited to losing his prize money and ranking points from the Indian Wells tournament, where he was eliminated in the semifinals.
How Did It Happen?
According to an investigation by the ITIA, the banned substance entered Sinner’s body accidentally. It was traced back to his physiotherapist, who used a product containing Clostebol to treat a finger injury. The physiotherapist was unaware that the product contained a banned substance and did not wear gloves while applying it, leading to the substance being absorbed into Sinner’s body.
Sinner’s Response
Sinner addressed the situation on social media, explaining that he learned of the positive test in April. He emphasized that the situation was unintentional and that he and his team are committed to following anti-doping rules strictly. He expressed relief that the issue is now behind him and reassured fans that he will continue to compete with integrity.
What’s Next for Sinner?
Since the positive test, Sinner has competed in eight tournaments, including the French Open and Wimbledon, where he reached the semifinals and quarterfinals, respectively. He also claimed victories at three events: the ATP 1000 tournaments in Miami and Cincinnati, and the Halle tournament. Sinner is set to compete in the upcoming US Open, starting on August 26.
Fans can follow the action live on Eurosport and the MAX platform.
